Recursion Pharmaceuticals Inc Cl A (RXRX)

$7.41 0.02 (0.27%)

16:00 EST RXRX Stock Quote Delayed 30 Minutes

2024’s Hidden Gems: 7 Small-Caps Set for Explosive Growth

By Jeremy Flint, InvestorPlace Contributor Nov 23, 2023

Small-cap stocks outperform larger companies on an indexed basis, but finding the best among them individually isn't always easy

AI Alert: 3 Healthcare Stocks That Are Investing in Artificial Intelligence

3 Stocks to Buy for Their Proximity to Nvidia

The 7 Best Cathie Wood Stocks to Buy Now: November Edition

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 4.17M

Day's Range $7.11 - $7.64

52-Week Range $4.54 - $16.75

Dividend & Yield N/A (N/A)

RXRX Stock Predictions, Articles, and Recursion Pharmaceuticals Inc Cl A News

From InvestorPlace
From the Web

3 Extra-Speculative Stocks That Could Make You Very, Very Rich

By Jeremy Flint, InvestorPlace Contributor Oct 26, 2023

Speculative stocks are a growth investor's dream—potential for untold riches, if you can find the stocks that will survive.

Immunomics Stocks: 3 Ways to Play This Massive AI-Biotech Megatrend

By John Blankenhorn, InvestorPlace Contributor Sep 22, 2023

Ginkgo Bioworks, Recursion Pharmaceutical, and Eli Lilly are cashing in on the AI-Biotech trend of tomorrow using the big data of today.

3 Biotech Stocks to Invest In for Big-Time, Long-Term Gains

By Muslim Farooque, InvestorPlace Contributor Sep 5, 2023

These biotech stocks to buy and hold offer tremendous upside blending long-term potential with healthcare advances.

Want to Get Rich? 3 Game-Changing Biotech Stocks to Buy Right Now

By Ian Cooper, InvestorPlace Contributor Aug 21, 2023

Biotech stocks may offer some of the most explosive opportunities on the market. Here are three with major catalysts nearing.

3 AI Stocks You’ll Regret Not Buying Soon

By Ian Cooper, InvestorPlace Contributor Aug 8, 2023

AI will have a big impact on biotech, which could help with drug discovery and create opportunities for these top AI stocks to invest in.

Did Nvidia Just Trigger a Short Squeeze in RXRX Stock?

By Bret Kenwell, InvestorPlace Contributor Jul 19, 2023

Recursion Pharmaceuticals continues to rally higher, with RXRX stock now up more than 100% after Nvidia invested in the firm last week.

3 Biotech Stocks Using AI to Change Healthcare Forever

By Jeremy Flint, InvestorPlace Contributor Jul 14, 2023

The past year provided a peek into the future of biotech and healthcare. Megafirms like Medtronic (NYSE:MDT) led the way, partnering with tech giants such....

Did Nvidia Make Recursion Pharmaceuticals (RXRX) Stock the Next AI Play?

By Shrey Dua, InvestorPlace Assistant News Writer Jul 13, 2023

RXRX stock is the talk of Wall Street today after Recursion Pharmaceuticals shot up 100% on a new Nvidia investment.

RXRX Stock: Nvidia Investment Sends Recursion Pharmaceuticals Soaring

By Josh Enomoto, InvestorPlace Contributor Jul 12, 2023

Nvidia just invested millions into Recursion Pharmaceuticals, bolstering AI integration in biotech but also presenting risks for RXRX stock.

Looking for Biotech AI Stocks? 3 Names That Will Benefit From the AI Boom

By John Blankenhorn, InvestorPlace Contributor Jul 8, 2023

AI is changing the face of biotechnology and drug discovery. Don't miss out on the next big boom in biotech, here are 3 stocks to consider.

Cash In on the Longevity Boom: 3 Biotech Stocks to Buy Now

By Jeremy Flint, InvestorPlace Contributor Jun 29, 2023

With longevity back in the news, many investors are wondering which biotech stocks to buy to best cash in on the growing trend.

Recursion Pharmaceuticals Wants to 4X Its Supercomputing Power for AI With the Help of Nvidia. Here's Why It Matters.

From The Motley Fool Nov 26, 2023

Scaling up means having more power to bring to bear on core activities.

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

From The Motley Fool Nov 22, 2023

This Stock Could Soar by 120%, According to Wall Street

From The Motley Fool Nov 22, 2023

Don't rush to buy shares just yet.

Cathie Wood Just Made a Big Bet on Recursion Pharmaceuticals Stock. Will It Pay Off?

From The Motley Fool Nov 21, 2023

Cathie Wood just gave the company a huge vote of confidence.

Unlocking AI investment opportunities in healthcare

From MarketBeat Nov 16, 2023

AI is revolutionizing healthcare by improving diagnosis and accelerating drug discovery. An often-overlooked sector with a wealth of AI opportunities.

2 Risky Stocks With Massive Potential

From The Motley Fool Oct 17, 2023

Neither is doing well this year.

Recursion Pharmaceuticals Inc Cl A (RXRX)

2024’s Hidden Gems: 7 Small-Caps Set for Explosive Growth

AI Alert: 3 Healthcare Stocks That Are Investing in Artificial Intelligence

3 Stocks to Buy for Their Proximity to Nvidia

The 7 Best Cathie Wood Stocks to Buy Now: November Edition

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Recursion Pharmaceuticals Inc Cl A (RXRX)

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

RXRX Stock Predictions, Articles, and Recursion Pharmaceuticals Inc Cl A News

Subscriber Sign in